State health officials offer clinical considerations in light of new CDC recommendation.
On November 2, 2021, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended use of the Pfizer-BioNTech 10mcg COVID-19 vaccine in children ages 5-11 years in the United States. This comes after the U.S. Food and Drug Administration (FDA) expanded its Emergency Use Authorization (EUA) for the Pfizer-BioNTech 10mcg COVID-19 vaccine to include this age group on Oct. 29, 2021. Previously the Pfizer vaccine was authorized for those ages 12 years and older in a higher dosage.
The Nevada Department of Health and Human Services has issued a technical bulletin that addresses clinical considerations such as dosages; side effects; packaging, storage and handling of the vaccine; and co-administration with other childhood vaccines. Visit the Division of Public and Behavioral Health website to read the technical bulletin.
For more information, guidance and resources about the COVID-19 response in Nevada, visit https://nvhealthresponse.nv.gov/.